Botox maker Allergan (NYSE:AGN) had a forgettable 2017. The branded pharma giant, after all, lost 22% of its value last year, according to data from S&P Global Market Intelligence.

What’s behind Allergan’s sinking share price? Two things:

Read the full article at www.fool.com